CUSIP 230031106COMCGEMQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
152 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 8.96M | $92.77M | +3.20M | Added |
| 2 | Mpm Bioimpact LLC | 7.65M | $79.16M | 0 | Held |
| 3 | Bvf Inc/Il | 5.75M | $59.52M | 0 | Held |
| 4 | Blackrock, Inc. | 4.40M | $45.54M |
| +230.3K |
| Added |
| 5 | Vanguard Group Inc | 3.30M | $34.14M | +355.2K | Added |
| 6 | Kynam Capital Management, LP | 3.11M | $32.23M | +812.0K | Added |
| 7 | Blue Owl Capital Holdings LP | 2.35M | $24.33M | −160.0K | Reduced |
| 8 | State Street Corp | 2.20M | $22.74M | +520.0K | Added |
| 9 | Affinity Asset Advisors, LLC | 1.93M | $20.00M | +1.67M | Added |
| 10 | Rtw Investments, LP | 1.71M | $17.66M | 0 | Held |
See every fund holding Cullinan Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders